| ¿µ¹® | myocardial infarction | ÇÑ±Û | ½É±Ù°æ»öÁõ |
|---|---|---|---|
| ¼³¸í | ½ÉÀå¿¡ ÇǸ¦ °ø±ÞÇÏ´Â Ç÷°üÀÌ ¸·Çô¼, ±× µ¿¸Æ¿¡ ÀÇÇØ ¿µ¾çºÐÀ» °ø±Þ¹Þ´Â ºÎÀ§°¡ ±«»ç(Á״´ٴ ¶æ)¿¡ ºüÁö´Â °ÍÀ» ¸»ÇÔ. ÁÖ·Î µ¿¸Æ°æÈÁõ(µ¿¸Æ¿¡ Áö¹æ¼ººÐ, ÁÖ·Î ÄÝ·¹½ºÅ×·Ñ µîÀÌ ½×¿© µ¿¸ÆÀÌ ±»¾î¼ µüµüÇØÁö´Â º´Àû»óÅÂ) µîÀ¸·Î Ç÷°üÀÌ Á¼¾ÆÁ® ÀÖ´Â »óÅ¿¡¼ Ç÷Àü(ÀûÇ÷±¸, Ç÷¼ÒÆÇ µî ÇÇÀÇ ¼ººÐÀÌ ¹¶Ãļ ¹ß»ý) ÀÌ ¹ß»ýÇϰųª, Áö³ªÄ£ µ¿¸Æ°æÈÁõÀÚü µî¿¡ ÀÇÇØ ¹ß»ýÇÑ´Ù. ÇöÀç ¹Ì±¹ µî, ¼±Áø±¹¿¡¼ÀÇ °¡Àå Å« »ç¸Á¿äÀÎÀÌ µÇ°í ÀÖ´Ù.¡¡ ¶ÇÇÑ ÀÌ ÁÖÀ§¿¡´Â ´ë°³ ½É±ÙÇãÇ÷ºÎÀ§°¡ Á¸ÀçÇϴµ¥ ÀÌ ºÎÀ§´Â ÇöÀç Çǰ¡ ¸ðÀÚ¶ó¼ ¸· ±«»ç¿¡ ºüÁö±â Á÷ÀüÀÇ ¼¼Æ÷°¡ ÀÖ´Â ºÎÀ§ÀÌ´Ù. µû¶ó¼ ÀÌ ÇãÇ÷»óÅ¿¡¼ ºü¸¥ Ä¡·á¸¦ ½ÃÇàÇÏ¿© Çǰ¡ °ø±ÞµÇ¸é, ÀÌ ºÎÀ§´Â Á¤»óÀûÀÎ »óÅ·ΠµÇ°ÚÁö¸¸, ¸¸¾à °è¼Ó ÀÌ »óÅ·ΠÀÖ°Ô µÇ¸é, ¾ðÁ¨°¡´Â ¿ª½Ã °æ»öÁõ¿¡ ºüÁ® ½ÉÀå¿îµ¿¿¡ ¸·´ëÇÑ ÁöÀåÀ» ÃÊ·¡ÇÏ°Ô µÉ °ÍÀÌ´Ù. |
||
| I/R | ischemia/reperfusion |
|---|---|
| RP | radial pulse; radiopharmaceutical; rapid processing [of film]; Raynaud phenomenon; reactive protein;... |
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
| AMI | acquired monosaccharide intolerance; acute myocardial infarction; amitriptyline; anterior myocardial... |
| IMI | immunologically measurable insulin; impending myocardial infarction; Imperial Mycological Institute ... |
| MI-R | myocardial ischemia-reperfusion |
|---|---|
| I-R | ischaemic-reperfusion |
| I-R | ischemia-reperfusion injury |
| IRI | Ischaemia-reperfusion injury |
| I/R | Ischemia and reperfusion |
| myocardial reperfusion | Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing myocardial reperfusion injury. (12 Dec 1998) |
|---|---|
| myocardial reperfusion injury | Functional, metabolic, or structural changes in ischemic heart muscle thought to result from reperfusion to the ischemic areas. Changes can be fatal to muscle cells and may include oedema with explosive cell swelling and disintegration, sarcolemma disruption, fragmentation of mitochondria, contraction band necrosis, enzyme washout, and calcium overload. Other damage may include haemorrhage and ventricular arrhythmias. One possible mechanism of damage is thought to be oxygen free radicals. Treatment currently includes the introduction of scavengers of oxygen free radicals, and injury is thought to be prevented by warm blood cardioplegic infusion prior to reperfusion. (12 Dec 1998) |
| reperfusion | The restoration of blood flow to an organ or tissue. After a heart attack, an immediate goal is to quickly open blocked arteries and reperfuse the heart muscles. Early reperfusion minimises the extent of heart muscle damage and preserves the pumping function of the heart. (12 Dec 1998) |
|---|---|
| reperfusion injury | Functional, metabolic, or structural changes, including necrosis, in ischemic tissues thought to result from reperfusion to ischemic areas of the tissue. The most common instance is myocardial reperfusion injury. (12 Dec 1998) |
| anterior myocardial infarction | Infarction involving the anterior wall of the heart, and producing indicative electrocardiographic changes in the anterior chest leads and often in limb lead I. (05 Mar 2000) |
| anteroinferior myocardial infarction | Infarction involving both anterior and inferior walls of the heart simultaneously. (05 Mar 2000) |
| anterolateral myocardial infarction | Extensive anterior infarction producing indicative changes across the precordium as well as in leads I and aVL. (05 Mar 2000) |
| anteroseptal myocardial infarction | An anterior infarction in which indicative electrocardiographic changes are confined to the medial chest leads (V1-V4). (05 Mar 2000) |
| biopsy, myocardial | <investigation, procedure, surgery> A procedure which involves the removal of a small specimen of cardiac muscle tissue for microscopic analysis. This is generally performed at the same time as a cardiac catheterisation or as a very similar, yet separate, procedure. A small piece of heart tissue is taken via a small forceps inserted into the cardiac catheter site (usually threaded through a vein in the neck). This test may reveal the cause of a cardiomyopathy, myocarditis, amyloidosis or a heart transplant rejection. (21 Mar 1998) |
| myocardial | Refers to the heart's muscle mass. (09 Oct 1997) |
| myocardial biopsy | <procedure> A procedure which involves the removal of a small specimen of cardiac muscle tissue for microscopic analysis. This is generally performed at the same time as a cardiac catheterisation or as a very similar, yet separate, procedure. A small piece of heart tissue is taken via a small forceps inserted into the cardiac catheter site (usually threaded through a vein in the neck). This test may reveal the cause of a cardiomyopathy, myocarditis, amyloidosis or a heart transplant rejection. (27 Sep 1997) |
| myocardial bridge | A bridge of cardiac muscle fibres extending over the epicardial aspect of a coronary artery; this finding, in cases of sudden unexpected death, has led to speculation that cardiac contraction during exertion could constrict the coronary artery. (05 Mar 2000) |
| myocardial contraction | Contractile activity of the heart. (12 Dec 1998) |
| myocardial contusion | A bruise to the heart muscle, usually caused by a blunt force applied to the anterior thorax (motor vehicle accident). Commonly seen in association with a rib or sternum fracture. Complications include cardiac arrhythmias and death. (27 Sep 1997) |
| myocardial depressant factor | A low molecular weight peptide of about 800-1000 having a negative inotropic effect. It is released into the circulation during experimental haemorrhagic pancreatitis, severe ischemia, and postoligaemic shock. (12 Dec 1998) |
| myocardial diseases | Diseases of the myocardium. (12 Dec 1998) |
| myocardial infarct imaging | <radiology> Tc-99m pyrophosphate (PYP) 20 mCi, peak abnormality 2-3 days, often falsely negative before 2 days, abnormal for 7-10 days, mechanism: calcium influx into ischemic cells, PYP incorporated into crystalline structure, analogous to hydroxyapatite see: nuclear cardiology (12 Dec 1998) |
Synonyms : Coronary Reperfusions, Myocardial Reperfusions, Reperfusion, Coronary, Reperfusions, Coronary, Reperfusions, Myocardial
Synonyms : Injury, Myocardial Reperfusion, Myocardial Ischemic Reperfusion Injury, Injuries, Myocardial Reperfusion, Myocardial Reperfusion Injuries, Reperfusion Injuries, Myocardial
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|